- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-risk Leukemias in Australia
Total 586 results
-
Medical University of ViennaRecruitingClinical High Risk for Psychosis | Ultra-high Risk for Psychosis | At-risk Mental StateAustria
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
OrygenNational Institute of Mental Health (NIMH); University of California, Davis; University...UnknownPersonality Disorders | Psychotic Disorders | Clinical High RiskAustralia
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
Australasian Leukaemia and Lymphoma GroupMerck Sharp & Dohme LLC; Novartis PharmaceuticalsUnknownChronic Myeloid LeukaemiaAustralia
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University of SydneyMelbourne Health; Royal Brisbane and Women's HospitalUnknown
-
Royal North Shore HospitalRecruiting
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyActive, not recruitingAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Lin BioScience, IncLin BioScience Pty LtdRecruitingRelapsed or Resistant Acute LeukaemiasTaiwan, Australia
-
Novartis PharmaceuticalsCompletedAcute LeukemiasHungary, Belgium, Germany, Austria, Netherlands, Australia, Canada, Spain, Norway, United Kingdom, United States
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Celgene CorporationCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Australia
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicAustralia, United States, New Zealand
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)France, Australia
-
Medical University of ViennaActive, not recruitingCardiovascular Risk FactorAustria
-
Peter MacCallum Cancer Centre, AustraliaUnknownMultiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid LeukaemiaAustralia
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeAustralia
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
Bayside HealthUnknownAcute Myeloid LeukemiaAustralia
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
Bayside HealthGilead SciencesUnknown
-
CSL LimitedCompletedAcute Myeloid Leukemia (AML)Australia
-
medac GmbHSyneos Health; CelerionCompletedMyelodysplastic Syndromes (MDS) | Acute Lymphoblastic Leukaemias (ALL) | Acute Myeloid Leukaemias (AML) | Juvenile Myelomonocytic Leukaemias (JMML)Germany, United Kingdom, Italy, Austria, Czechia, Poland
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMyelodysplastic Syndrome (MDS) | Acute Myeloid Leukaemia (AML)United States, Australia, France, Spain
-
German Cancer Research CenterUniversity Hospital Freiburg; ABX CRO; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedProstate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode MetastasisAustria, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Eilean TherapeuticsNot yet recruiting
-
Medical University of ViennaCompletedPerioperative | Brain Natriuretic Peptide | Supplemental Oxygen | Cardiac Risk PatientsAustria
-
CelgeneCompletedLeukemia, Myeloid, AcuteKorea, Republic of, Australia
-
University of AdelaideCompletedIndividuals at Risk of Developing DiabetesAustralia
-
Shengke Pharmaceuticals Pty LtdTerminatedLeukemia | NHLAustralia
-
Monash UniversityRecruitingCardiovascular Risk Factors | Cognitive Function 1, Social | Poor Glycemic ControlAustralia
-
Ellipses PharmaRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia, Netherlands, United Kingdom
-
Janssen Research & Development, LLCRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute LeukemiasUnited States, United Kingdom, France, Spain, Australia
-
Flinders Universitymedac GmbH; University of South AustraliaRecruitingRheumatoid Arthritis | Endothelial Dysfunction | Cardiovascular Risk Factor | Stiffness, AorticAustralia
-
SanofiRecruitingMyelodysplastic Syndromes | Acute Lymphocytic Leukaemia | Acute Myeloid Leukaemia Refractory | Blastic Plasmacytoid Dendritic Cell NeoplasiaNetherlands, France, United States, Australia, China